Aurinia starts PRESERVE trial combining LUPKYNIS with biologics in lupus nephritisAug 6Quarterly updateAurinia Pharmaceuticals Inc.voclosporin
Ocrevus higher-dose Phase 3 posts results, misses primary endpoint; two partner trials updateJul 24Weekly roundup, 4 itemsobinutuzumabocrelizumab
Sign inSign in